nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2D6—Alzheimer's disease	0.29	1	CbGaD
Tolterodine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0857	0.179	CbGbCtD
Tolterodine—CYP2C19—Memantine—Alzheimer's disease	0.0781	0.164	CbGbCtD
Tolterodine—CYP2C9—Donepezil—Alzheimer's disease	0.0749	0.157	CbGbCtD
Tolterodine—CYP2D6—Donepezil—Alzheimer's disease	0.0685	0.143	CbGbCtD
Tolterodine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0545	0.114	CbGbCtD
Tolterodine—CYP2D6—Galantamine—Alzheimer's disease	0.0441	0.0924	CbGbCtD
Tolterodine—CYP3A4—Donepezil—Alzheimer's disease	0.0436	0.0912	CbGbCtD
Tolterodine—CYP3A4—Galantamine—Alzheimer's disease	0.0281	0.0588	CbGbCtD
Tolterodine—Xerophthalmia—Memantine—Alzheimer's disease	0.0068	0.0443	CcSEcCtD
Tolterodine—Dementia—Donepezil—Alzheimer's disease	0.00492	0.0321	CcSEcCtD
Tolterodine—Dementia—Rivastigmine—Alzheimer's disease	0.00437	0.0285	CcSEcCtD
Tolterodine—Delusion—Donepezil—Alzheimer's disease	0.00285	0.0186	CcSEcCtD
Tolterodine—Delusion—Memantine—Alzheimer's disease	0.00259	0.0169	CcSEcCtD
Tolterodine—Influenza-like symptoms—Memantine—Alzheimer's disease	0.00257	0.0167	CcSEcCtD
Tolterodine—Delusion—Rivastigmine—Alzheimer's disease	0.00253	0.0165	CcSEcCtD
Tolterodine—Influenza-like symptoms—Rivastigmine—Alzheimer's disease	0.00251	0.0164	CcSEcCtD
Tolterodine—Gastrooesophageal reflux disease—Memantine—Alzheimer's disease	0.00203	0.0132	CcSEcCtD
Tolterodine—Gastrooesophageal reflux disease—Rivastigmine—Alzheimer's disease	0.00198	0.0129	CcSEcCtD
Tolterodine—Dry eye—Donepezil—Alzheimer's disease	0.00186	0.0121	CcSEcCtD
Tolterodine—Urinary retention—Galantamine—Alzheimer's disease	0.0018	0.0117	CcSEcCtD
Tolterodine—Influenza like illness—Memantine—Alzheimer's disease	0.00178	0.0116	CcSEcCtD
Tolterodine—Abnormal vision—Donepezil—Alzheimer's disease	0.00176	0.0115	CcSEcCtD
Tolterodine—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00174	0.0113	CcSEcCtD
Tolterodine—Abnormal vision—Memantine—Alzheimer's disease	0.0016	0.0104	CcSEcCtD
Tolterodine—Bronchitis—Galantamine—Alzheimer's disease	0.00157	0.0102	CcSEcCtD
Tolterodine—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00156	0.0102	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00152	0.0099	CcSEcCtD
Tolterodine—Disorientation—Memantine—Alzheimer's disease	0.00149	0.00969	CcSEcCtD
Tolterodine—Urinary tract infection—Galantamine—Alzheimer's disease	0.00142	0.00923	CcSEcCtD
Tolterodine—Urinary retention—Donepezil—Alzheimer's disease	0.00139	0.00908	CcSEcCtD
Tolterodine—Dry skin—Donepezil—Alzheimer's disease	0.00134	0.00875	CcSEcCtD
Tolterodine—Hallucination—Galantamine—Alzheimer's disease	0.0013	0.00848	CcSEcCtD
Tolterodine—Oedema peripheral—Galantamine—Alzheimer's disease	0.00129	0.0084	CcSEcCtD
Tolterodine—Urinary retention—Memantine—Alzheimer's disease	0.00126	0.00824	CcSEcCtD
Tolterodine—Visual impairment—Galantamine—Alzheimer's disease	0.00126	0.00821	CcSEcCtD
Tolterodine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00124	0.00806	CcSEcCtD
Tolterodine—Dry skin—Memantine—Alzheimer's disease	0.00122	0.00795	CcSEcCtD
Tolterodine—Bronchitis—Donepezil—Alzheimer's disease	0.00122	0.00794	CcSEcCtD
Tolterodine—Flushing—Galantamine—Alzheimer's disease	0.00121	0.00791	CcSEcCtD
Tolterodine—Dry skin—Rivastigmine—Alzheimer's disease	0.00119	0.00777	CcSEcCtD
Tolterodine—Dysuria—Donepezil—Alzheimer's disease	0.00118	0.00772	CcSEcCtD
Tolterodine—Weight increased—Donepezil—Alzheimer's disease	0.00115	0.00751	CcSEcCtD
Tolterodine—Flatulence—Galantamine—Alzheimer's disease	0.00112	0.00731	CcSEcCtD
Tolterodine—Bronchitis—Memantine—Alzheimer's disease	0.00111	0.00721	CcSEcCtD
Tolterodine—Urinary tract infection—Donepezil—Alzheimer's disease	0.0011	0.00715	CcSEcCtD
Tolterodine—Bronchitis—Rivastigmine—Alzheimer's disease	0.00108	0.00705	CcSEcCtD
Tolterodine—Dysuria—Memantine—Alzheimer's disease	0.00108	0.00701	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00107	0.00696	CcSEcCtD
Tolterodine—Dysuria—Rivastigmine—Alzheimer's disease	0.00105	0.00685	CcSEcCtD
Tolterodine—Weight increased—Memantine—Alzheimer's disease	0.00105	0.00682	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00105	0.00681	CcSEcCtD
Tolterodine—Weight increased—Rivastigmine—Alzheimer's disease	0.00102	0.00667	CcSEcCtD
Tolterodine—Vertigo—Galantamine—Alzheimer's disease	0.00102	0.00667	CcSEcCtD
Tolterodine—Hallucination—Donepezil—Alzheimer's disease	0.00101	0.00657	CcSEcCtD
Tolterodine—Palpitations—Galantamine—Alzheimer's disease	0.00101	0.00656	CcSEcCtD
Tolterodine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000998	0.00651	CcSEcCtD
Tolterodine—Urinary tract infection—Memantine—Alzheimer's disease	0.000996	0.00649	CcSEcCtD
Tolterodine—Visual impairment—Donepezil—Alzheimer's disease	0.000977	0.00637	CcSEcCtD
Tolterodine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000975	0.00635	CcSEcCtD
Tolterodine—Arthralgia—Galantamine—Alzheimer's disease	0.000969	0.00632	CcSEcCtD
Tolterodine—Chest pain—Galantamine—Alzheimer's disease	0.000969	0.00632	CcSEcCtD
Tolterodine—Anxiety—Galantamine—Alzheimer's disease	0.000966	0.00629	CcSEcCtD
Tolterodine—Sinusitis—Memantine—Alzheimer's disease	0.000962	0.00627	CcSEcCtD
Tolterodine—Dry mouth—Galantamine—Alzheimer's disease	0.000948	0.00618	CcSEcCtD
Tolterodine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000941	0.00613	CcSEcCtD
Tolterodine—Confusional state—Galantamine—Alzheimer's disease	0.000937	0.00611	CcSEcCtD
Tolterodine—Hallucination—Memantine—Alzheimer's disease	0.000916	0.00597	CcSEcCtD
Tolterodine—Tachycardia—Galantamine—Alzheimer's disease	0.000907	0.00591	CcSEcCtD
Tolterodine—Oedema peripheral—Memantine—Alzheimer's disease	0.000907	0.00591	CcSEcCtD
Tolterodine—Hallucination—Rivastigmine—Alzheimer's disease	0.000896	0.00584	CcSEcCtD
Tolterodine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000887	0.00578	CcSEcCtD
Tolterodine—Visual impairment—Memantine—Alzheimer's disease	0.000887	0.00578	CcSEcCtD
Tolterodine—Flatulence—Donepezil—Alzheimer's disease	0.000869	0.00567	CcSEcCtD
Tolterodine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000868	0.00565	CcSEcCtD
Tolterodine—CHRM4—nervous system—Alzheimer's disease	0.000865	0.0527	CbGeAlD
Tolterodine—CHRM2—forebrain—Alzheimer's disease	0.000855	0.0521	CbGeAlD
Tolterodine—Flushing—Memantine—Alzheimer's disease	0.000854	0.00557	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000846	0.00552	CcSEcCtD
Tolterodine—Flushing—Rivastigmine—Alzheimer's disease	0.000835	0.00544	CcSEcCtD
Tolterodine—CHRM4—central nervous system—Alzheimer's disease	0.000833	0.0507	CbGeAlD
Tolterodine—Somnolence—Galantamine—Alzheimer's disease	0.000826	0.00538	CcSEcCtD
Tolterodine—Dyspepsia—Galantamine—Alzheimer's disease	0.000818	0.00533	CcSEcCtD
Tolterodine—Fatigue—Galantamine—Alzheimer's disease	0.000801	0.00522	CcSEcCtD
Tolterodine—Constipation—Galantamine—Alzheimer's disease	0.000795	0.00518	CcSEcCtD
Tolterodine—Vertigo—Donepezil—Alzheimer's disease	0.000793	0.00517	CcSEcCtD
Tolterodine—Flatulence—Memantine—Alzheimer's disease	0.000789	0.00514	CcSEcCtD
Tolterodine—CHRM2—telencephalon—Alzheimer's disease	0.000786	0.0479	CbGeAlD
Tolterodine—CHRM1—forebrain—Alzheimer's disease	0.000778	0.0474	CbGeAlD
Tolterodine—Flatulence—Rivastigmine—Alzheimer's disease	0.000772	0.00503	CcSEcCtD
Tolterodine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000766	0.00499	CcSEcCtD
Tolterodine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00076	0.00495	CcSEcCtD
Tolterodine—Arthralgia—Donepezil—Alzheimer's disease	0.000751	0.0049	CcSEcCtD
Tolterodine—Chest pain—Donepezil—Alzheimer's disease	0.000751	0.0049	CcSEcCtD
Tolterodine—Anxiety—Donepezil—Alzheimer's disease	0.000749	0.00488	CcSEcCtD
Tolterodine—Dry mouth—Donepezil—Alzheimer's disease	0.000735	0.00479	CcSEcCtD
Tolterodine—Abdominal pain—Galantamine—Alzheimer's disease	0.000734	0.00479	CcSEcCtD
Tolterodine—Confusional state—Donepezil—Alzheimer's disease	0.000726	0.00473	CcSEcCtD
Tolterodine—Oedema—Donepezil—Alzheimer's disease	0.00072	0.00469	CcSEcCtD
Tolterodine—Vertigo—Memantine—Alzheimer's disease	0.00072	0.00469	CcSEcCtD
Tolterodine—CHRM1—telencephalon—Alzheimer's disease	0.000715	0.0436	CbGeAlD
Tolterodine—Infection—Donepezil—Alzheimer's disease	0.000715	0.00466	CcSEcCtD
Tolterodine—Palpitations—Memantine—Alzheimer's disease	0.000708	0.00461	CcSEcCtD
Tolterodine—Vertigo—Rivastigmine—Alzheimer's disease	0.000704	0.00459	CcSEcCtD
Tolterodine—CHRM3—forebrain—Alzheimer's disease	0.000696	0.0424	CbGeAlD
Tolterodine—Palpitations—Rivastigmine—Alzheimer's disease	0.000693	0.00451	CcSEcCtD
Tolterodine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000685	0.00446	CcSEcCtD
Tolterodine—Chest pain—Memantine—Alzheimer's disease	0.000682	0.00444	CcSEcCtD
Tolterodine—Arthralgia—Memantine—Alzheimer's disease	0.000682	0.00444	CcSEcCtD
Tolterodine—Anxiety—Memantine—Alzheimer's disease	0.00068	0.00443	CcSEcCtD
Tolterodine—CHRM5—nervous system—Alzheimer's disease	0.000676	0.0412	CbGeAlD
Tolterodine—Atomoxetine—HTR6—Alzheimer's disease	0.000675	0.221	CrCbGaD
Tolterodine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000667	0.00435	CcSEcCtD
Tolterodine—Chest pain—Rivastigmine—Alzheimer's disease	0.000667	0.00435	CcSEcCtD
Tolterodine—Dry mouth—Memantine—Alzheimer's disease	0.000667	0.00435	CcSEcCtD
Tolterodine—Asthenia—Galantamine—Alzheimer's disease	0.000667	0.00434	CcSEcCtD
Tolterodine—Anxiety—Rivastigmine—Alzheimer's disease	0.000665	0.00433	CcSEcCtD
Tolterodine—Fesoterodine—CYP2D6—Alzheimer's disease	0.000663	0.217	CrCbGaD
Tolterodine—CHRM4—brain—Alzheimer's disease	0.000661	0.0403	CbGeAlD
Tolterodine—Confusional state—Memantine—Alzheimer's disease	0.000659	0.0043	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000656	0.00428	CcSEcCtD
Tolterodine—Oedema—Memantine—Alzheimer's disease	0.000654	0.00426	CcSEcCtD
Tolterodine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000653	0.00425	CcSEcCtD
Tolterodine—CHRM5—central nervous system—Alzheimer's disease	0.000651	0.0397	CbGeAlD
Tolterodine—Infection—Memantine—Alzheimer's disease	0.00065	0.00423	CcSEcCtD
Tolterodine—Confusional state—Rivastigmine—Alzheimer's disease	0.000645	0.0042	CcSEcCtD
Tolterodine—CHRM3—telencephalon—Alzheimer's disease	0.00064	0.039	CbGeAlD
Tolterodine—Somnolence—Donepezil—Alzheimer's disease	0.00064	0.00417	CcSEcCtD
Tolterodine—Oedema—Rivastigmine—Alzheimer's disease	0.00064	0.00417	CcSEcCtD
Tolterodine—Tachycardia—Memantine—Alzheimer's disease	0.000638	0.00416	CcSEcCtD
Tolterodine—Diarrhoea—Galantamine—Alzheimer's disease	0.000636	0.00414	CcSEcCtD
Tolterodine—Infection—Rivastigmine—Alzheimer's disease	0.000635	0.00414	CcSEcCtD
Tolterodine—Dyspepsia—Donepezil—Alzheimer's disease	0.000634	0.00413	CcSEcCtD
Tolterodine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000624	0.00407	CcSEcCtD
Tolterodine—Fatigue—Donepezil—Alzheimer's disease	0.000621	0.00405	CcSEcCtD
Tolterodine—KCNH2—forebrain—Alzheimer's disease	0.000617	0.0376	CbGeAlD
Tolterodine—Pain—Donepezil—Alzheimer's disease	0.000616	0.00401	CcSEcCtD
Tolterodine—Constipation—Donepezil—Alzheimer's disease	0.000616	0.00401	CcSEcCtD
Tolterodine—Dizziness—Galantamine—Alzheimer's disease	0.000614	0.004	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000596	0.00388	CcSEcCtD
Tolterodine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000593	0.00387	CcSEcCtD
Tolterodine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000589	0.00384	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000583	0.0038	CcSEcCtD
Tolterodine—Headache—Galantamine—Alzheimer's disease	0.000582	0.00379	CcSEcCtD
Tolterodine—Somnolence—Memantine—Alzheimer's disease	0.000581	0.00379	CcSEcCtD
Tolterodine—Dyspepsia—Memantine—Alzheimer's disease	0.000575	0.00375	CcSEcCtD
Tolterodine—Abdominal pain—Donepezil—Alzheimer's disease	0.000569	0.00371	CcSEcCtD
Tolterodine—Somnolence—Rivastigmine—Alzheimer's disease	0.000569	0.00371	CcSEcCtD
Tolterodine—KCNH2—telencephalon—Alzheimer's disease	0.000568	0.0346	CbGeAlD
Tolterodine—Fatigue—Memantine—Alzheimer's disease	0.000564	0.00367	CcSEcCtD
Tolterodine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000563	0.00367	CcSEcCtD
Tolterodine—Pain—Memantine—Alzheimer's disease	0.000559	0.00364	CcSEcCtD
Tolterodine—Constipation—Memantine—Alzheimer's disease	0.000559	0.00364	CcSEcCtD
Tolterodine—Fatigue—Rivastigmine—Alzheimer's disease	0.000551	0.00359	CcSEcCtD
Tolterodine—Constipation—Rivastigmine—Alzheimer's disease	0.000547	0.00356	CcSEcCtD
Tolterodine—Pain—Rivastigmine—Alzheimer's disease	0.000547	0.00356	CcSEcCtD
Tolterodine—Feeling abnormal—Memantine—Alzheimer's disease	0.000539	0.00351	CcSEcCtD
Tolterodine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000535	0.00348	CcSEcCtD
Tolterodine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000531	0.00346	CcSEcCtD
Tolterodine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000527	0.00343	CcSEcCtD
Tolterodine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000523	0.00341	CcSEcCtD
Tolterodine—Abdominal pain—Memantine—Alzheimer's disease	0.000517	0.00337	CcSEcCtD
Tolterodine—CHRM5—brain—Alzheimer's disease	0.000517	0.0315	CbGeAlD
Tolterodine—Asthenia—Donepezil—Alzheimer's disease	0.000517	0.00337	CcSEcCtD
Tolterodine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000506	0.00329	CcSEcCtD
Tolterodine—Diarrhoea—Donepezil—Alzheimer's disease	0.000493	0.00321	CcSEcCtD
Tolterodine—Hypersensitivity—Memantine—Alzheimer's disease	0.000482	0.00314	CcSEcCtD
Tolterodine—Dizziness—Donepezil—Alzheimer's disease	0.000476	0.0031	CcSEcCtD
Tolterodine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000471	0.00307	CcSEcCtD
Tolterodine—Asthenia—Memantine—Alzheimer's disease	0.000469	0.00306	CcSEcCtD
Tolterodine—CHRM2—nervous system—Alzheimer's disease	0.000464	0.0283	CbGeAlD
Tolterodine—Asthenia—Rivastigmine—Alzheimer's disease	0.000459	0.00299	CcSEcCtD
Tolterodine—Headache—Donepezil—Alzheimer's disease	0.000451	0.00294	CcSEcCtD
Tolterodine—Diarrhoea—Memantine—Alzheimer's disease	0.000447	0.00292	CcSEcCtD
Tolterodine—CHRM2—central nervous system—Alzheimer's disease	0.000447	0.0272	CbGeAlD
Tolterodine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000438	0.00285	CcSEcCtD
Tolterodine—Dizziness—Memantine—Alzheimer's disease	0.000432	0.00282	CcSEcCtD
Tolterodine—Dizziness—Rivastigmine—Alzheimer's disease	0.000423	0.00276	CcSEcCtD
Tolterodine—CHRM1—nervous system—Alzheimer's disease	0.000422	0.0257	CbGeAlD
Tolterodine—Headache—Memantine—Alzheimer's disease	0.00041	0.00267	CcSEcCtD
Tolterodine—CHRM1—central nervous system—Alzheimer's disease	0.000407	0.0248	CbGeAlD
Tolterodine—Headache—Rivastigmine—Alzheimer's disease	0.000401	0.00261	CcSEcCtD
Tolterodine—CHRM3—nervous system—Alzheimer's disease	0.000378	0.023	CbGeAlD
Tolterodine—CYP2D6—forebrain—Alzheimer's disease	0.000377	0.0229	CbGeAlD
Tolterodine—CHRM3—central nervous system—Alzheimer's disease	0.000364	0.0222	CbGeAlD
Tolterodine—CHRM2—brain—Alzheimer's disease	0.000355	0.0216	CbGeAlD
Tolterodine—CYP2D6—telencephalon—Alzheimer's disease	0.000346	0.0211	CbGeAlD
Tolterodine—KCNH2—nervous system—Alzheimer's disease	0.000335	0.0204	CbGeAlD
Tolterodine—Labetalol—CYP2D6—Alzheimer's disease	0.00033	0.108	CrCbGaD
Tolterodine—CHRM1—brain—Alzheimer's disease	0.000323	0.0197	CbGeAlD
Tolterodine—KCNH2—central nervous system—Alzheimer's disease	0.000323	0.0197	CbGeAlD
Tolterodine—KCNH2—cerebellum—Alzheimer's disease	0.000315	0.0192	CbGeAlD
Tolterodine—Chlorphenamine—SLC6A4—Alzheimer's disease	0.000308	0.101	CrCbGaD
Tolterodine—CHRM3—brain—Alzheimer's disease	0.000289	0.0176	CbGeAlD
Tolterodine—Atomoxetine—SLC6A4—Alzheimer's disease	0.000258	0.0847	CrCbGaD
Tolterodine—KCNH2—brain—Alzheimer's disease	0.000256	0.0156	CbGeAlD
Tolterodine—Brompheniramine—CYP2D6—Alzheimer's disease	0.00022	0.0722	CrCbGaD
Tolterodine—Chlorphenamine—CYP2D6—Alzheimer's disease	0.000216	0.0709	CrCbGaD
Tolterodine—CYP3A4—nervous system—Alzheimer's disease	0.000208	0.0127	CbGeAlD
Tolterodine—CYP2D6—nervous system—Alzheimer's disease	0.000204	0.0125	CbGeAlD
Tolterodine—CYP3A4—central nervous system—Alzheimer's disease	0.0002	0.0122	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—Alzheimer's disease	0.000199	0.0651	CrCbGaD
Tolterodine—CYP2D6—central nervous system—Alzheimer's disease	0.000197	0.012	CbGeAlD
Tolterodine—CYP2D6—cerebellum—Alzheimer's disease	0.000192	0.0117	CbGeAlD
Tolterodine—Atomoxetine—CYP2D6—Alzheimer's disease	0.000182	0.0595	CrCbGaD
Tolterodine—CYP2D6—brain—Alzheimer's disease	0.000156	0.00952	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	1.06e-05	0.000177	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	1.06e-05	0.000177	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.05e-05	0.000177	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	1.05e-05	0.000176	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.04e-05	0.000175	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.04e-05	0.000175	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	1.04e-05	0.000174	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.04e-05	0.000174	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	1.03e-05	0.000173	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.03e-05	0.000173	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.02e-05	0.000171	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.02e-05	0.000171	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	1.02e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	1.01e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.01e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—LPL—Alzheimer's disease	1.01e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	1.01e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	1.01e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	1.01e-05	0.000169	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	1.01e-05	0.000169	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1e-05	0.000169	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	1e-05	0.000168	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1e-05	0.000168	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—F2—Alzheimer's disease	9.96e-06	0.000167	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	9.87e-06	0.000166	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	9.87e-06	0.000166	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.84e-06	0.000165	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	9.75e-06	0.000164	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	9.69e-06	0.000162	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	9.68e-06	0.000162	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	9.66e-06	0.000162	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	9.63e-06	0.000161	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.6e-06	0.000161	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	9.6e-06	0.000161	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	9.57e-06	0.000161	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—F2—Alzheimer's disease	9.54e-06	0.00016	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	9.5e-06	0.000159	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.49e-06	0.000159	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	9.33e-06	0.000157	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	9.17e-06	0.000154	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	9.17e-06	0.000154	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	9.15e-06	0.000153	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	9.14e-06	0.000153	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—Alzheimer's disease	9.12e-06	0.000153	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	9.08e-06	0.000152	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	9.08e-06	0.000152	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	9.07e-06	0.000152	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	9.05e-06	0.000152	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—INS—Alzheimer's disease	9.02e-06	0.000151	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	9e-06	0.000151	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	9e-06	0.000151	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	8.88e-06	0.000149	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	8.86e-06	0.000149	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	8.83e-06	0.000148	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.82e-06	0.000148	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	8.76e-06	0.000147	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	8.75e-06	0.000147	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	8.73e-06	0.000146	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	8.69e-06	0.000146	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	8.66e-06	0.000145	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—INS—Alzheimer's disease	8.64e-06	0.000145	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CALM1—Alzheimer's disease	8.52e-06	0.000143	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	8.5e-06	0.000143	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	8.5e-06	0.000143	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.49e-06	0.000142	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOE—Alzheimer's disease	8.49e-06	0.000142	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	8.47e-06	0.000142	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	8.44e-06	0.000142	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	8.42e-06	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CAV1—Alzheimer's disease	8.41e-06	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	8.39e-06	0.000141	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	8.39e-06	0.000141	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	8.39e-06	0.000141	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.37e-06	0.00014	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	8.36e-06	0.00014	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	8.31e-06	0.000139	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	8.26e-06	0.000139	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	8.23e-06	0.000138	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	8.17e-06	0.000137	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	8.17e-06	0.000137	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	8.15e-06	0.000137	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	8.05e-06	0.000135	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	8.02e-06	0.000135	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.96e-06	0.000134	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	7.94e-06	0.000133	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	7.91e-06	0.000133	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.89e-06	0.000132	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.83e-06	0.000131	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	7.83e-06	0.000131	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	7.8e-06	0.000131	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.74e-06	0.00013	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	7.73e-06	0.00013	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.72e-06	0.000129	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	7.66e-06	0.000128	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.65e-06	0.000128	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	7.64e-06	0.000128	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	7.58e-06	0.000127	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	7.56e-06	0.000127	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.54e-06	0.000126	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PPARG—Alzheimer's disease	7.4e-06	0.000124	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.28e-06	0.000122	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—INS—Alzheimer's disease	7.25e-06	0.000122	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	7.23e-06	0.000121	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	7.2e-06	0.000121	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	7.15e-06	0.00012	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	7.12e-06	0.00012	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	7.12e-06	0.000119	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	7.12e-06	0.000119	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	7.1e-06	0.000119	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	7.1e-06	0.000119	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	7.06e-06	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	7.06e-06	0.000118	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	7.03e-06	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	7.03e-06	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	7.03e-06	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	6.97e-06	0.000117	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	6.8e-06	0.000114	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	6.78e-06	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	6.78e-06	0.000114	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	6.72e-06	0.000113	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	6.72e-06	0.000113	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	6.71e-06	0.000113	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—F2—Alzheimer's disease	6.69e-06	0.000112	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	6.67e-06	0.000112	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.65e-06	0.000112	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	6.63e-06	0.000111	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.62e-06	0.000111	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.59e-06	0.000111	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—LPL—Alzheimer's disease	6.58e-06	0.00011	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.57e-06	0.00011	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.56e-06	0.00011	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	6.55e-06	0.00011	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	6.49e-06	0.000109	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.49e-06	0.000109	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	6.43e-06	0.000108	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	6.39e-06	0.000107	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NOS3—Alzheimer's disease	6.36e-06	0.000107	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.33e-06	0.000106	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.26e-06	0.000105	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	6.17e-06	0.000104	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	6.17e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	6.16e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	6.15e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	6.12e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	6.1e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	6.09e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	6.08e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	6.06e-06	0.000102	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—LPL—Alzheimer's disease	6.06e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	6.04e-06	0.000101	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	6.01e-06	0.000101	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—LPL—Alzheimer's disease	6e-06	0.000101	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	5.99e-06	0.0001	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	5.97e-06	0.0001	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.93e-06	9.95e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.93e-06	9.95e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.93e-06	9.94e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	5.91e-06	9.92e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	5.91e-06	9.91e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	5.9e-06	9.89e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	5.89e-06	9.87e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	5.87e-06	9.84e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.82e-06	9.76e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	5.82e-06	9.76e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	5.81e-06	9.74e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	5.7e-06	9.56e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	5.54e-06	9.29e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—Alzheimer's disease	5.52e-06	9.26e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.52e-06	9.25e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	5.47e-06	9.17e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	5.46e-06	9.16e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.45e-06	9.15e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.41e-06	9.07e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	5.34e-06	8.95e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	5.32e-06	8.92e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	5.27e-06	8.83e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	5.23e-06	8.78e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.21e-06	8.73e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	5.09e-06	8.55e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—Alzheimer's disease	5.08e-06	8.52e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	5.05e-06	8.47e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.05e-06	8.46e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—Alzheimer's disease	5.03e-06	8.44e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	5.03e-06	8.44e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	5.01e-06	8.4e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.99e-06	8.36e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.81e-06	8.06e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INS—Alzheimer's disease	4.72e-06	7.91e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.57e-06	7.67e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	4.56e-06	7.64e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	4.53e-06	7.6e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	4.52e-06	7.57e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.51e-06	7.57e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	4.5e-06	7.55e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	4.49e-06	7.52e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	4.47e-06	7.5e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.44e-06	7.45e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.42e-06	7.42e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.38e-06	7.35e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.35e-06	7.3e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INS—Alzheimer's disease	4.34e-06	7.27e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.33e-06	7.26e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	4.31e-06	7.23e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INS—Alzheimer's disease	4.3e-06	7.21e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	4.16e-06	6.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	4.15e-06	6.96e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	4.15e-06	6.96e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	4.14e-06	6.94e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	4.13e-06	6.94e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	4.13e-06	6.92e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	4.11e-06	6.89e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	4.1e-06	6.87e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.96e-06	6.64e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	3.94e-06	6.61e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.84e-06	6.45e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	3.83e-06	6.43e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.8e-06	6.38e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	3.79e-06	6.36e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.78e-06	6.34e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	3.78e-06	6.33e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.77e-06	6.32e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	3.64e-06	6.1e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.57e-06	5.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.53e-06	5.92e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	3.52e-06	5.9e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	3.48e-06	5.84e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.48e-06	5.84e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.48e-06	5.83e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.45e-06	5.78e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.33e-06	5.59e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.32e-06	5.57e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.29e-06	5.52e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AKT1—Alzheimer's disease	2.92e-06	4.9e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.9e-06	4.87e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	2.9e-06	4.86e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.89e-06	4.85e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	2.87e-06	4.81e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.84e-06	4.76e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.66e-06	4.46e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.65e-06	4.45e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.62e-06	4.4e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.49e-06	4.17e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.45e-06	4.11e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.44e-06	4.1e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.42e-06	4.06e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.27e-06	3.81e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.9e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.75e-06	2.93e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.73e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.14e-06	1.92e-05	CbGpPWpGaD
